Vertex Pharmaceuticals outpaced the broader market, closing up 1.19% while major indices mostly tiptoed forward. Over the ...

Vertex Pharmaceuticals (VRTX) reachead $509.47 at the closing of the latest trading day, reflecting a +1.19% change compared to its last close.

Shares of Vertex Pharmaceuticals Inc. VRTX rallied 1.19% to $509.50 Wednesday, on what proved to be an all-around positive ...

Vertex, Inc. (NASDAQ: VERX) began Wednesday trading downward. The King of Prussia, Pa.-based company, a global provider of indirect tax technology solutions, announced it has completed a strategic ...

Vertex, Inc. (NASDAQ: VERX) ("Vertex" or the "Company"), a global provider of indirect tax technology solutions, today announced it has completed ...

Iovance Biotherapeutics (NASDAQ: IOVA) and CRISPR Therapeutics (NASDAQ: CRSP) are two incredibly innovative biotechs, but ...

Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a global provider of indirect tax technology solutions, today announced it has completed a strategic investment in Kintsugi, a San ...

We recently published a list of the 30 Stocks That Should Double in 3 Years. In this article, we are going to take a look at ...

Buying $1000 In VRTX: If an investor had bought $1000 of VRTX stock 10 years ago, it would be worth $3,986.54 today based on ...

Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the ...

You can still find attractive stocks despite all of the turbulence. Many stocks have been losers in 2025 amid the market chaos, but not Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B). Shares of Warren ...

In a report released today, Will Jellison from D.A. Davidson reiterated a Buy rating on SPS Commerce (SPSC – Research Report). The company’s ...